What You Should Know:
– Tempus, a provider of AI-driven precision medicine, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-owned subsidiary of the Menarini Group announced a new collaboration to improve the use of ESR1 testing…
Continue Reading
Groundbreaking £11M AI Initiative Launches
The Department for Health and Social Care (DHSC) has unveiled a revolutionary £11m pilot project that harnesses artificial intelligence to accelerate breast cancer detection. This innovative program will enable radiologists…
Revolutionary Findings in Breast Cancer Screening
A landmark clinical trial has revolutionized breast cancer screening by demonstrating the remarkable effectiveness of artificial intelligence in mammography. The Mammography Screening with Artificial Intelligence (MASAI) trial, published in…
The government has announced the launch of a trial that will test how AI tools can be used to detect cases of breast cancer earlier.
The Department of Health and Social Care (DHSC) confirmed that…
I tell the story in the talk about a particular algorithm that is able to pick out breast cancer cells and lymph nodes – very important. The algorithm alone was about 95%—that's pretty good….
Continue Reading
Premature frailty is a critical challenge for young breast cancer survivors (YBCSs), impacting their health and perpetuating gender inequality through heightened vulnerability and marginalization. While digital health shows promise in frailty screening, its effectiveness…
Continue Reading
Strategic Acquisition Enhances AI Capabilities
ScreenPoint Medical’s acquisition of Biomediq A/S on January 8, 2025, represents a milestone in AI-driven breast cancer detection. This strategic merger follows ten years of collaborative research, integrating Biomediq’s quantitative…
What You Should Know:
– ScreenPoint Medical, a provider of AI-powered breast cancer screening solutions, acquires Biomediq A/S, a research-based company specializing in quantitative imaging biomarkers. Financial details of the acquisition were not disclosed.
– ScreenPoint’s…
Continue Reading
In resource-constrained countries like India, mammography-based breast screening is challenging to implement. This state-wide study, funded by the Government of Punjab, evaluated the use of Thermalytix, a low-cost, radiation-free AI tool, for breast cancer…
Continue Reading
“AI in diagnostics is where the future is going to be. And I think our kids will look back on healthcare now and think, ‘Oh my gosh, radiologists used to just read those images…
Continue Reading
